Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

April 1, 2022

Study Completion Date

June 1, 2022

Conditions

Neutropenia

Interventions

DRUG

Lithium Carbonate

400 mg tablet in controlled released formula

Trial Locations (1)

Al-Azhar University, Cairo

All Listed Sponsors

lead

Al-Azhar University

OTHER

NCT05221593 - Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients | Biotech Hunter | Biotech Hunter